Revolution Medicines

RVMDNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$41.315 B

$192.76 +0.95%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

214,336,418

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Revolution Medicines lists more than one class of stock. Company figures above cover all classes combined.

RVMDW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#3ModernaMRNA$69.0B
#4Argenx SeARGX$61.3B
#5Revolution MedicinesRVMD$41.3B
#6BiogenBIIB$32.4B
#7BioNTech SEBNTX$24.6B

What if Revolution Medicines were worth as much as…

Open the what-if tool →

Gold $30.3T

$141,245.50

Per share 733× higher

Bitcoin $1.72T

$8,023.85

Per share 41.6× higher

Nvidia $5.48T

$25,566.62

Per share 133× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Revolution Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.